Dr. Said is the founder and CEO of Outcomes4Me, a health technology company focused on providing patients diagnosed with cancer and other chronic diseases with personalized treatment options as well as outcomes information. She currently serves on the Board of Directors of two immune-focused biotech companies, Transgene and Pieris Pharmaceuticals. She was the COO of Celsius Therapeutics, an autoimmune disease and cancer-focused biotech company.

Prior to founding Outcomes4Me, she spent many years as a senior pharmaceutical executive at both Novartis and Sanofi leading global functions, including Market Access, Policy, R&D Strategy and Business Development. Earlier in her career, she was a Principal at the Boston Consulting Group and a founding member of its Strategy Institute. Maya trained at the Massachusetts Institute of Technology (MIT), earning dual degrees in Biology and Electrical Engineering and Computer Science (EECS) with a minor in Economics. She also holds a Master of Science in Toxicology, a Master of Engineering in EECS and a Doctor of Science in Electrical Engineering, Computer Science and Systems Biology, all from MIT.